483 Boehringer Ingelheim RCV & CO KG Nov 2018

483 Boehringer Ingelheim RCV & CO KG Nov 2018

Richard Ledwidge FDA, Maria Lopez- Barragan FDA, Ram Sihag FDA$119.00 - Available Now

FDA investigators audited the Boehringer Ingelheim RCV & CO KG - Vienna, Austria facility and issued inspectional observations (via FDA 483) on 23 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Nov 2018
  • Location: Vienna, Austria
  • FEI: 3003433722
Add To Cart